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• Limited effective interventions for pregnant smokers
- Varenicline and Buproprion2 - Nicotine Replacement Therapy2
- Physical activity interventions3 - 1-to-1 behavioural support4
- Financial incentives5 - Self-help6
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Background
• 12% of women in UK smoke throughout pregnancy1
• #1 preventable cause of pregnancy and infant ill-health
• Limited effective interventions for pregnant smokers
- Varenicline and Buproprion2 - Nicotine Replacement Therapy2
- Physical activity interventions3 - 1-to-1 behavioural support4
- Financial incentives5 - Self-help6
• Self-help effective but not routinely used
– Text messaging has wide reach potential + effective for non-pregnant smokers7
– Unknown if effective for pregnancy smokers
1 NHS Information Centre (2010), 2 Coleman et al (2015) Cochrane Database Syst Rev, 3 Ussher et al (2015) BMJ, 
4 Chamberlain et al (2013) Cochrane Database Syst Rev, 5 Tappin et al (2015) BMJ, 6 Naughton et al (2008) Addiction,                
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MiQuit
• 12 weeks of automated, interactive, pregnancy-
specific support & advice by text
• Tailored to 14 characteristics including:
– Motivation - Nicotine dependence
– Self-efficacy - Smoking partner
– Most difficult situation - Gestation
+    Smoking status during programme
MiQuit
• 12 weeks of automated, interactive, pregnancy-
specific support & advice by text
• Tailored to 14 characteristics including:
– Motivation - Nicotine dependence
– Self-efficacy - Smoking partner
– Most difficult situation - Gestation
+    Smoking status during programme
• ‘Push’ support: 6 core text types (~1-2 per day)
– Motivation - Preparation
– Self-efficacy enhancing - Outcome expectancies
– Relapse prevention - Postpartum
• ‘Pull’ support: on demand automated response 
– HELP (if craving) - SLIP (if lapsed)
– QUIZ (game for distraction)
• Additional features
– Change text frequency - Baby development texts
– Text in quit date for extra support
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Development
- Feasible and acceptable
- MiQuit increased motivation, 
self-efficacy and harm beliefs
- Increased setting of quit date
Aims
• To estimate the likely effectiveness and cost-effectiveness 
of a theory-guided, tailored, text message cessation 
program specifically for pregnant smokers
• To estimate the key parameters for delivering a full, UK-
wide trial
– Recruitment and outcome ascertainment rates
Study design  
 Multicentre, parallel group, single-blinded RCT
Setting
 16 antenatal screening clinics in England (recruited Feb-Sept 2014)
Eligibility criteria
 Age ≥16, pregnant (<25 weeks gestation)
 Smoking at least 5/day pre-pregnancy and at least 1/day now
 NOT receiving any other text service to assist cessation
Methods
Randomly allocated to receive 12 week text 
service (MiQuit) plus a standard NHS self-help 
leaflet, or leaflet only (Control)
Followed up by telephone:
4 weeks  - self report quits
If a quit reported at 36 wks - Validation  
Saliva and/or breath samples
(visit where possible)
Participants identified and recruited in NHS 
antenatal clinics by NIHR CRN research staff
Followed up by telephone:
Late pregnancy (36 weeks) – self reported quits
Screened
1181
Enrolled
407 
WEEK 4
295 out of an expected 407 
(72.5 % follow-up rate)
36 WEEKS GESTATION 
251 out of an expected 397
(63 % follow-up rate)
Validation of Smoking Status
37 of 64 self-reports (58 %)
Trial Process and flow
Smoking outcomes
• Anticipated primary outcome for definitive trial:
– Prolonged abstinence from 4 weeks post-enrolment till late pregnancy 
(36 weeks) biochemically validated in late pregnancy (5 cigs max 
permitted8)
• Six additional smoking outcomes, including:
– 7 day abstinence at 4 weeks post-baseline FU (self-report only)
– 7 day abstinence at late pregnancy FU (self-report & validated)
– 7 day abstinence at both follow ups (self-report & validated)
• Intention to treat. Missing = smoking assumption8
8 West et al (2005) Addiction
Results
Participant characteristics
• Mean gestation = 15 weeks, mean age = 26
• Range of motivation to quit:
• 95% had not set a quit date at baseline
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Smoking outcomes
Outcome MiQuit
N=203 (%)
Usual  Care
N=204 (%)
Adjusted odds 
ratio (95% CI)*
PRIMARY SMOKING OUTCOME
Prolonged, validated abstinence
from 4 weeks post-baseline until 
late pregnancy
11 (5.42) 4 (1.96) 2.70 (0.93-9.35)
*Adjusted by site and gestation at randomisation, 95% profile confidence intervals reported
Smoking outcomes
Outcome MiQuit
N=203 (%)
Usual  Care
N=204 (%)
Adjusted odds 
ratio (95% CI)*
PRIMARY SMOKING OUTCOME
Prolonged, validated abstinence
from 4 weeks post-baseline until 
late pregnancy
11 (5.42) 4 (1.96) 2.70 (0.93-9.35)
• Other smoking outcomes favoured MiQuit over usual 
care (adjusted odds ratios 1.03 to 3.28)
• 83% MiQuit, 75% usual care participants made at 
least one quit attempt (p=0.10)
*Adjusted by site and gestation at randomisation, 95% profile confidence intervals reported
Attitudes to MiQuit intervention
• 27 / 203 MiQuit participants (13.3%) sent a ‘STOP’ message
• Of MiQuit ppts present at late pregnancy follow up (N=120):
– 98% reported receiving text messages
– 81% read all messages at least once
– 81% ‘probably’ or ‘definitely’ would recommend MiQuit
– 62% rated the messages as ‘quite’ or ‘extremely’ helpful
– 14% rated the messages as annoying
• Most helpful element of the text message support?
– Messages relating to fetal development (35% participants)
Economic analysis
• Per-participant cost of sending texts:
– £2.95 (mean 84 texts x 3.5p each)
• Annual MiQuit running cost:
– £339 (£1.67 pp)
• Total cost per participant = £4.62
Economic analysis
• Per-participant cost of sending texts:
– £2.95 (mean 84 texts x 3.5p each)
• Annual MiQuit running cost:
– £339 (£1.67 pp)
• Total cost per participant = £4.62
• Incremental quit rate = 3.46%
• Incremental cost per additional quitter
£133.53 (95% CI -£395.78 - £843.62)
Summary 1
• Largest RCT of SMS intervention for pregnant smokers
• Recruitment and outcome measures feasible
• High fidelity of intervention delivery (98%)
• Suggest MiQuit could more than double quit rates
Summary 1
• Largest RCT of SMS intervention for pregnant smokers
• Recruitment and outcome measures feasible
• High fidelity of intervention delivery (98%)
• Suggest MiQuit could more than double quit rates
• Low cost per quitter estimate (£133):
– ~10 times lower than £ incentives (£1,127)9
– ~5 times lower than routine NHS specialist support (£~600)10
9 Boyd et al (2016) Addiction, 10 Dobbie et al (2015) Health Technol Assess
Summary 2
• MiQuit designed to be implemented in routine care
• 1-page info leaflet in booking notes --> 3-4% uptake11
• Can also reach pregnant smokers online through 
Google search adverts and Facebook
– Jo Emery’s talk: Gordon A suite, Sat 09.30
11 Naughton et al (2015) BMJ Open
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